Authors:
Slocum, HK
Parsons, JC
Winslow, EO
Broderick, L
Minderman, H
Toth, K
Greco, WR
Rustum, YM
Citation: Hk. Slocum et al., Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694), CYTOMETRY, 41(4), 2000, pp. 252-260
Authors:
Yin, MB
Guo, B
Vanhoefer, U
Azrak, RG
Minderman, H
Frank, C
Wrzosek, C
Slocum, HK
Rustum, YMN
Citation: Mb. Yin et al., Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a noveltopoisomerase I inhibitor BNP1350, MOLEC PHARM, 57(3), 2000, pp. 453-459
Authors:
Cao, SS
Lu, K
Toth, K
Slocum, HK
Shirasaka, T
Rustum, YM
Citation: Ss. Cao et al., Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model, CLIN CANC R, 5(2), 1999, pp. 267-274
Authors:
Yin, MB
Toth, K
Cao, SS
Guo, B
Frank, C
Slocum, HK
Rustum, YM
Citation: Mb. Yin et al., Involvement of cyclin D1-CDK5 overexpression and MCM3 cleavage in bax-associated spontaneous apoptosis and differentiation in an A253 human head and neck carcinoma xenograft model, INT J CANC, 83(3), 1999, pp. 341-348
Authors:
Yin, MB
Guo, B
Panadero, A
Frank, C
Wrzosek, C
Slocum, HK
Rustum, YM
Citation: Mb. Yin et al., Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex, EXP CELL RE, 247(1), 1999, pp. 189-199
Authors:
Faessel, HM
Slocum, HK
Rustum, YM
Greco, WR
Citation: Hm. Faessel et al., Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034) - Comparison across sensitive and resistant human tumor cell lines, BIOCH PHARM, 57(5), 1999, pp. 567-577
Authors:
Levasseur, LM
Faessel, H
Slocum, HK
Greco, WR
Citation: Lm. Levasseur et al., Implications for clinical pharmacodynamic studies of the statistical characterization of an in vitro antiproliferation assay, J PHAR BIOP, 26(6), 1998, pp. 717-733